Castration-sensitive Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-sensitive Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC [Phase 3]
Phase 3 trial evaluating intermittent ADT with apalutamide monotherapy in metastatic castration-sensitive prostate cancer (mCSPC) is active …
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. [Phase 3]
Phase 3 trial investigating whether combining Mevrometostat (PF-06821497) with enzalutamide improves outcomes versus enzalutamide alone in A…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC [Phase 3]
Pfizer is conducting a Phase 3 study of talazoparib in combination with enzalutamide for men with DDR gene-mutated metastatic castration-sen…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating adaptive androgen deprivation in combination with docetaxel for metastatic castration-sensitive prostate…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC [Phase 3]
Phase 3 clinical trial update describing an ongoing study of intermittent androgen deprivation therapy with apalutamide monotherapy in metas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer [Phase 1]
Phase 1 safety and dose-finding study of PRL-02 Depot in men with advanced prostate cancer is currently recruiting, indicating early clinica…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer-sponsored real-world evidence study on metastatic prostate cancer (metastatic castration-sensitive and metastatic castration-resistan…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) [Phase 3]
Phase 3 study evaluating niraparib plus abiraterone and prednisone versus abiraterone alone in HRR gene-mutated metastatic castration-sensit…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) [Phase 3]
Phase 3 trial evaluating niraparib in combination with abiraterone acetate and prednisone vs abiraterone acetate and prednisone in HRR gene-…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer-sponsored clinical trial evaluating novel hormonal therapies for metastatic castration-sensitive prostate cancer has completed, with …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
A clinical trial update reporting completion of a study evaluating apalutamide and enzalutamide in metastatic castration-sensitive prostate …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer [Phase 3]
Phase 3 trial evaluating shorter-duration androgen receptor pathway inhibitor therapy with apalutamide and enzalutamide for patients with lo…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer [Phase 1]
This ClinicalTrials.gov update reports the completion of a Phase 1 study evaluating relugolix in men with metastatic castration-sensitive an…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Pfizer conducted a study of novel hormonal therapies for metastatic castration-sensitive prostate cancer that has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer [Phase 3]
Phase 3 trial update for TAVT-45 (Abiraterone Acetate) granules in metastatic prostate cancer patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial evaluating antiandrogen therapy (abiraterone acetate) with or without neutron radiation therapy in castration-sensitive/pros…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan [Phase 4]
A Phase 4 trial update evaluating circulating tumor DNA in metastatic castration-sensitive prostate cancer patients in Japan treated with ap…
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer [Phase 2]
Phase 2 trial investigating docetaxel or abiraterone acetate with androgen deprivation therapy for metastatic hormone-sensitive prostate can…